{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:01:01Z","timestamp":1744156861368},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00403-005-0572-x","type":"journal-article","created":{"date-parts":[[2005,5,18]],"date-time":"2005-05-18T14:12:01Z","timestamp":1116425521000},"page":"26-30","source":"Crossref","is-referenced-by-count":14,"title":["Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions"],"prefix":"10.1007","volume":"297","author":[{"given":"Claudia S.","family":"Vetter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"M\u00fcller-Blech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Schrama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-B.","family":"Br\u00f6cker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,15]]},"reference":[{"issue":"55","key":"572_CR1","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1038\/sj.onc.1204985","volume":"20","author":"GM Kasof","year":"2001","unstructured":"Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV (2001) Tumor Necrosis Factor-Alpha Induces the Expression of DR6, a Member of the TNF Receptor Family, Through Activation of NF-KappaB. Oncogene 20(55):7965\u20137975","journal-title":"Oncogene"},{"issue":"8","key":"572_CR2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","volume":"3","author":"G Ambrosini","year":"1997","unstructured":"Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma. Nat Med 3(8):917\u2013921","journal-title":"Nat Med"},{"issue":"3","key":"572_CR3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/eje.0.1460381","volume":"146","author":"CA Koch","year":"2002","unstructured":"Koch CA, Vortmeyer AO, Diallo R, Poremba C, Giordano TJ, Sanders D, Bornstein SR, Chrousos GP, Pacak K (2002) Survivin: a novel neuroendocrine marker for pheochromocytoma. Eur J Endocrinol 146(3):381\u2013388","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"572_CR4","first-page":"1921","volume":"96","author":"C Adida","year":"2000","unstructured":"Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC, Molina TJ (2000) Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96(5):1921\u20131925","journal-title":"Blood"},{"issue":"6","key":"572_CR5","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1523-1747.1999.00776.x","volume":"113","author":"D Grossman","year":"1999","unstructured":"Grossman D, McNiff JM, Li F, Altieri DC (1999) Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 113(6):1076\u20131081","journal-title":"J Invest Dermatol"},{"issue":"9","key":"572_CR6","first-page":"1121","volume":"79","author":"D Grossman","year":"1999","unstructured":"Grossman D, McNiff JM, Li F, Altieri DC (1999) Expression of the apoptosis Inhibitor, Survivin, in Nonmelanoma Skin Cancer and Gene Targeting in a keratinocyte cell line. lab invest 79(9):1121\u20131126","journal-title":"Lab Invest"},{"issue":"1","key":"572_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1523-1747.2003.12010.x","volume":"120","author":"AR Bowen","year":"2003","unstructured":"Bowen AR, Hanks AN, Allen SM, Alexander A, Diedrich MJ, Grossman D (2003) Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J Invest Dermatol 120(1):48\u201355","journal-title":"J Invest Dermatol"},{"issue":"5","key":"572_CR8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.onc.1203358","volume":"19","author":"A Islam","year":"2000","unstructured":"Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A (2000) High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. oncogene 19(5):617\u2013623","journal-title":"Oncogene"},{"issue":"6","key":"572_CR9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM199908053410614","volume":"341","author":"HS Swana","year":"1999","unstructured":"Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341(6):452\u2013453","journal-title":"N Engl J Med"},{"issue":"8","key":"572_CR10","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.4049\/jimmunol.161.8.4183","volume":"161","author":"KH Lee","year":"1998","unstructured":"Lee KH, Panelli MC, Kim CJ, Riker AI, Bettinotti MP, Roden MM, Fetsch P, Abati A, Rosenberg SA, Marincola FM (1998) Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination. J Immunol 161(8):4183\u20134194","journal-title":"J Immunol"},{"key":"572_CR11","unstructured":"Ambrosini G, Adida C, Sirugo G, Altieri DC. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting"},{"key":"572_CR12","unstructured":"Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients"},{"issue":"1","key":"572_CR13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2407-4-62","volume":"4","author":"J Fensterle","year":"2004","unstructured":"Fensterle J, Becker JC, Potapenko T, Heimbach V, Vetter CS, Brocker EB, Rapp UR (2004) B-Raf specific antibody responses in melanoma patients. BMC Cancer 4(1):62","journal-title":"BMC Cancer"},{"issue":"5","key":"572_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1471-4914(01)02013-5","volume":"7","author":"K Satyamoorthy","year":"2001","unstructured":"Satyamoorthy K, Bogenrieder T, Herlyn M (2001) No longer a molecular black box\u2014new clues to apoptosis and drug resistance in melanoma. Trends Mol Med 7(5):191\u2013194","journal-title":"Trends Mol Med"},{"issue":"5","key":"572_CR15","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.161.5.2195","volume":"161","author":"WD Thomas","year":"1998","unstructured":"Thomas WD, Hersey P (1998) TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol 161(5):2195\u20132200","journal-title":"J Immunol"},{"issue":"8","key":"572_CR16","first-page":"1865","volume":"4","author":"L Tang","year":"1998","unstructured":"Tang L, Tron VA, Reed JC, Mah KJ, Krajewska M, Li G, Zhou X, Ho VC, Trotter MJ (1998) Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res 4(8):1865\u20131871","journal-title":"Clin Cancer Res"},{"issue":"6817","key":"572_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35051606","volume":"409","author":"MS Soengas","year":"2001","unstructured":"Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW (2001) Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409(6817):207\u2013211","journal-title":"Nature"},{"issue":"21","key":"572_CR18","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0960-9822(00)00781-8","volume":"10","author":"D Vucic","year":"2000","unstructured":"Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM (2000) ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 10(21):1359\u20131366","journal-title":"Curr Biol"},{"issue":"7","key":"572_CR19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0092-8674(91)90002-G","volume":"65","author":"GT Williams","year":"1991","unstructured":"Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65(7):1097\u20131098","journal-title":"Cell"},{"issue":"6368","key":"572_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/356397a0","volume":"356","author":"MC Raff","year":"1992","unstructured":"Raff MC (1992) Social controls on cell survival and cell death. Nature 356(6368):397\u2013400","journal-title":"Nature"},{"issue":"5","key":"572_CR21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0092-8674(93)90457-2","volume":"74","author":"GT Williams","year":"1993","unstructured":"Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74(5):777\u2013779","journal-title":"Cell"},{"issue":"17","key":"572_CR22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199904293401707","volume":"340","author":"BA Gilchrest","year":"1999","unstructured":"Gilchrest BA, Eller MS, Geller AC, Yaar M (1999) The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340(17):1341\u20131348","journal-title":"N Engl J Med"},{"issue":"1","key":"572_CR23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1523-1747.1999.00636.x","volume":"113","author":"T Alanko","year":"1999","unstructured":"Alanko T, Rosenberg M, Saksela O (1999) FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes. J Invest Dermatol 113(1):111\u2013116","journal-title":"J Invest Dermatol"},{"issue":"1","key":"572_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00008390-199802000-00004","volume":"8","author":"G Li","year":"1998","unstructured":"Li G, Tang L, Zhou X, Tron V, Ho V (1998) Chemotherapy-induced apoptosis in melanoma cells is P53 dependent. melanoma Res 8(1):17\u201323","journal-title":"Melanoma Res"},{"issue":"3","key":"572_CR25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/jcp.48.3.242","volume":"48","author":"EE Mooney","year":"1995","unstructured":"Mooney EE, Ruis Peris JM, O\u2019Neill A, Sweeney EC (1995) Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol 48(3):242\u2013244","journal-title":"J Clin Pathol"},{"issue":"20","key":"572_CR26","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/sj.onc.1206463","volume":"22","author":"BC Bastian","year":"2003","unstructured":"Bastian BC (2003) Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 22(20):3081\u20133086","journal-title":"Oncogene"},{"issue":"5","key":"572_CR27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1309\/6V09-38K3-JQ40-UR50","volume":"117","author":"M Frost","year":"2002","unstructured":"Frost M, Jarboe EA, Orlicky D, Gianani R, Thompson LC, Enomoto T, Shroyer KR (2002) Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol 117(5):738\u2013744","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"572_CR28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00008390-200008000-00001","volume":"10","author":"M Herlyn","year":"2000","unstructured":"Herlyn M, Berking C, Li G, Satyamoorthy K (2000) Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation. melanoma Res 10(4):303\u2013312","journal-title":"Melanoma Res"},{"issue":"5","key":"572_CR29","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/he.2000.6496","volume":"31","author":"T Ito","year":"2000","unstructured":"Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, Nakano T, Suzuki A (2000) Survivin promotes cell proliferation in human hepatocellular carcinoma. hepatology 31(5):1080\u20131085","journal-title":"Hepatology"},{"issue":"3","key":"572_CR30","first-page":"537","volume":"19","author":"H Yoshida","year":"2001","unstructured":"Yoshida H, Ishiko O, Sumi T, Matsumoto Y, Ogita S (2001) Survivin, Bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas. Int J Oncol 19(3):537\u2013542","journal-title":"Int J Oncol"},{"issue":"1","key":"572_CR31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjc.6600696","volume":"88","author":"P Grabowski","year":"2003","unstructured":"Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, Heine B, Stein H, Hopfner M, Germer CT, Scherubl H (2003) Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88(1):115\u2013119","journal-title":"Br J Cancer"},{"issue":"11","key":"572_CR32","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/emboj\/cdg263","volume":"22","author":"H Marusawa","year":"2003","unstructured":"Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, Reed JC (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J22(11):2729\u20132740","journal-title":"EMBO J"},{"key":"572_CR33","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.2741\/A341","volume":"3","author":"F Meier","year":"1998","unstructured":"Meier F, Satyamoorthy K, Nesbit M, Hsu MY, Schittek B, Garbe C, Herlyn M (1998) Molecular events in melanoma development and progression. front biosci 3:D1005\u2013D1010","journal-title":"Front Biosci"},{"issue":"4","key":"572_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1357-4310(00)01692-0","volume":"6","author":"G Li","year":"2000","unstructured":"Li G, Herlyn M (2000) Dynamics of intercellular communication during melanoma development. Mol Med Today 6(4):163\u2013169","journal-title":"Mol Med Today"},{"issue":"8","key":"572_CR35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archderm.1995.01690200051010","volume":"131","author":"CR Morales-Ducret","year":"1995","unstructured":"Morales-Ducret CR, van de Rijn M, Smoller BR (1995) Bcl-2 expression in melanocytic nevi. Insights into the biology of dermal maturation. Arch Dermatol 131(8):915\u2013918","journal-title":"Arch Dermatol"},{"issue":"2","key":"572_CR36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0560.1999.tb01805.x","volume":"26","author":"E Sprecher","year":"1999","unstructured":"Sprecher E, Bergman R, Meilick A, Kerner H, Manov L, Reiter I, Shafer Y, Maor G, Friedman-Birnbaum R (1999) Apoptosis, Fas and Fas-ligand expression in melanocytic tumors. J Cutan Pathol 26(2):72\u201377","journal-title":"J Cutan Pathol"},{"issue":"2","key":"572_CR37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000372-199904000-00003","volume":"21","author":"R Boni","year":"1999","unstructured":"Boni R, Wellmann A, Man YG, Hofbauer G, Brinkmann U (1999) Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesions. Am J Dermatopathol 21(2):125\u2013128","journal-title":"Am J Dermatopathol"},{"issue":"14","key":"572_CR38","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/sj.onc.1203507","volume":"19","author":"MG Shennan","year":"2000","unstructured":"Shennan MG, Badin AC, Walsh S, Summers A, From L, McKenzie M, Goldstein AM, Tucker MA, Hogg D, Lassam N (2000) Lack of germline CDK6 mutations in familial melanoma. Oncogene 19(14):1849\u20131852","journal-title":"Oncogene"},{"issue":"7","key":"572_CR39","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1128\/MCB.20.7.2358-2366.2000","volume":"20","author":"C Badie","year":"2000","unstructured":"Badie C, Itzhaki JE, Sullivan MJ, Carpenter AJ, Porter AC (2000) Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)\/M arrest in human cells. Mol Cell Biol 20(7):2358\u20132366","journal-title":"Mol Cell Biol"},{"issue":"Pt23","key":"572_CR40","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1242\/jcs.113.23.4363","volume":"113","author":"J Zhao","year":"2000","unstructured":"Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR (2000) The Ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 113(Pt23):4363\u20134371","journal-title":"J Cell Sci"},{"issue":"1","key":"572_CR41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1535-6108(02)00084-3","volume":"2","author":"DS O\u2019Connor","year":"2002","unstructured":"O\u2019Connor DS, Wall NR, Porter AC, Altieri DCA (2002) P34(Cdc2) survival checkpoint in cancer. Cancer Cell 2(1):43\u201354","journal-title":"Cancer Cell"},{"issue":"7","key":"572_CR42","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.V100.7.2463","volume":"100","author":"S Fukuda","year":"2002","unstructured":"Fukuda S, Foster RG, Porter SB, Pelus LM (2002) The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 100(7):2463\u20132471","journal-title":"Blood"},{"issue":"4","key":"572_CR43","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1073\/pnas.98.4.1543","volume":"98","author":"Y Shen","year":"2001","unstructured":"Shen Y, Devgan G, Darnell JE Jr, Bromberg JF (2001) Constitutively activated stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of Activated Stat1. Proc Natl Acad Sci U S A 98(4):1543\u20131548","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-005-0572-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-005-0572-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-005-0572-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T01:04:07Z","timestamp":1706231047000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-005-0572-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["572"],"URL":"https:\/\/doi.org\/10.1007\/s00403-005-0572-x","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}